Cargando…

Severe cytomegalovirus (CMV) community-acquired pneumonia (CAP) in a nonimmunocompromised host

BACKGROUND: Community-acquired pneumonia (CAP) in an immunocompetent host may be severe because of a variety or combination of host and microbial factors. In patients with severe cardiopulmonary dysfunction, even relatively avirulent pathogens, that is, Mycoplasma pneumoniae, Moraxella catarrhalis,...

Descripción completa

Detalles Bibliográficos
Autores principales: Cunha, Burke A., Pherez, Francisco, Walls, Nicole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mosby, Inc. 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112647/
https://www.ncbi.nlm.nih.gov/pubmed/19486794
http://dx.doi.org/10.1016/j.hrtlng.2008.05.008
_version_ 1783513513878093824
author Cunha, Burke A.
Pherez, Francisco
Walls, Nicole
author_facet Cunha, Burke A.
Pherez, Francisco
Walls, Nicole
author_sort Cunha, Burke A.
collection PubMed
description BACKGROUND: Community-acquired pneumonia (CAP) in an immunocompetent host may be severe because of a variety or combination of host and microbial factors. In patients with severe cardiopulmonary dysfunction, even relatively avirulent pathogens, that is, Mycoplasma pneumoniae, Moraxella catarrhalis, may compromise borderline cardiac/heart function and present clinically as severe CAP. Alternately, patients with Streptococcus pneumoniae and impaired humoral immunity/splenic dysfunction may present as severe CAP. With the exception of Legionnaire's disease, influenza, and adenovirus, pathogen virulence is not a key determinant of CAP severity. METHODS: Diagnostically, patients with severe CAP may be approached based on the pattern of infiltrates on chest x-ray together with the severity of hypoxemia (ie, increased A-a gradient: >35). RESULTS: We present the case of an immunocompetent adult who presented with severe CAP during peak influenza season. Direct fluorescent antibody testing of his respiratory secretions was negative for influenza, adenovirus, and other respiratory viruses. Diagnostic bronchoscopy was negative for bacterial and fungal pathogens. The only clues to the cause of his severe CAP was the presence of relative lymphopenia, atypical lymphocytosis and elevated serum transaminases. After influenza and adenovirus were ruled out, cytomegalovirus (CMV) CAP was considered. The diagnosis of CMV CAP was made serologically by demonstrating highly elevated IgM CMV titers. Because the diagnosis was made during the patient's recovery late in hospitalization, he did not receive CMV antiviral therapy. CONCLUSION: This case should remind clinicians that influenza and adenovirus are diagnostic considerations in patients presenting with severe CAP with diffuse bilateral interstitial infiltrates accompanied by severe hypoxemia in normal hosts. If influenza and adenovirus are ruled out, then CMV CAP, although rare, should be considered, particularly when viral CAP is accompanied by relative lymphopenia, atypical lymphocytosis and increased serum transaminases.
format Online
Article
Text
id pubmed-7112647
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Mosby, Inc.
record_format MEDLINE/PubMed
spelling pubmed-71126472020-04-02 Severe cytomegalovirus (CMV) community-acquired pneumonia (CAP) in a nonimmunocompromised host Cunha, Burke A. Pherez, Francisco Walls, Nicole Heart Lung Article BACKGROUND: Community-acquired pneumonia (CAP) in an immunocompetent host may be severe because of a variety or combination of host and microbial factors. In patients with severe cardiopulmonary dysfunction, even relatively avirulent pathogens, that is, Mycoplasma pneumoniae, Moraxella catarrhalis, may compromise borderline cardiac/heart function and present clinically as severe CAP. Alternately, patients with Streptococcus pneumoniae and impaired humoral immunity/splenic dysfunction may present as severe CAP. With the exception of Legionnaire's disease, influenza, and adenovirus, pathogen virulence is not a key determinant of CAP severity. METHODS: Diagnostically, patients with severe CAP may be approached based on the pattern of infiltrates on chest x-ray together with the severity of hypoxemia (ie, increased A-a gradient: >35). RESULTS: We present the case of an immunocompetent adult who presented with severe CAP during peak influenza season. Direct fluorescent antibody testing of his respiratory secretions was negative for influenza, adenovirus, and other respiratory viruses. Diagnostic bronchoscopy was negative for bacterial and fungal pathogens. The only clues to the cause of his severe CAP was the presence of relative lymphopenia, atypical lymphocytosis and elevated serum transaminases. After influenza and adenovirus were ruled out, cytomegalovirus (CMV) CAP was considered. The diagnosis of CMV CAP was made serologically by demonstrating highly elevated IgM CMV titers. Because the diagnosis was made during the patient's recovery late in hospitalization, he did not receive CMV antiviral therapy. CONCLUSION: This case should remind clinicians that influenza and adenovirus are diagnostic considerations in patients presenting with severe CAP with diffuse bilateral interstitial infiltrates accompanied by severe hypoxemia in normal hosts. If influenza and adenovirus are ruled out, then CMV CAP, although rare, should be considered, particularly when viral CAP is accompanied by relative lymphopenia, atypical lymphocytosis and increased serum transaminases. Mosby, Inc. 2009 2008-10-01 /pmc/articles/PMC7112647/ /pubmed/19486794 http://dx.doi.org/10.1016/j.hrtlng.2008.05.008 Text en Copyright © 2009 Mosby, Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Cunha, Burke A.
Pherez, Francisco
Walls, Nicole
Severe cytomegalovirus (CMV) community-acquired pneumonia (CAP) in a nonimmunocompromised host
title Severe cytomegalovirus (CMV) community-acquired pneumonia (CAP) in a nonimmunocompromised host
title_full Severe cytomegalovirus (CMV) community-acquired pneumonia (CAP) in a nonimmunocompromised host
title_fullStr Severe cytomegalovirus (CMV) community-acquired pneumonia (CAP) in a nonimmunocompromised host
title_full_unstemmed Severe cytomegalovirus (CMV) community-acquired pneumonia (CAP) in a nonimmunocompromised host
title_short Severe cytomegalovirus (CMV) community-acquired pneumonia (CAP) in a nonimmunocompromised host
title_sort severe cytomegalovirus (cmv) community-acquired pneumonia (cap) in a nonimmunocompromised host
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112647/
https://www.ncbi.nlm.nih.gov/pubmed/19486794
http://dx.doi.org/10.1016/j.hrtlng.2008.05.008
work_keys_str_mv AT cunhaburkea severecytomegaloviruscmvcommunityacquiredpneumoniacapinanonimmunocompromisedhost
AT pherezfrancisco severecytomegaloviruscmvcommunityacquiredpneumoniacapinanonimmunocompromisedhost
AT wallsnicole severecytomegaloviruscmvcommunityacquiredpneumoniacapinanonimmunocompromisedhost